Volkswagen’s Q2 Profits Plummet; CEO Seeks Savings Plan Clarity by Year-End
Volkswagen reports Q2 profits dip as struggles continue, with CEO Oliver Blume seeking clarity on savings plans by year's end.
Monthly Archives
July 2026
President Trump Orders Warning Signs in Front of Smithsonian Museum
President Trump seeks control of Smithsonian Institution's museums, ordering warning signs about "inaccurate…
Ask to Split $2,100 Medicare Drug Bill into Monthly Payments.
Medicare allows splitting of $2,100 annual drug bill into monthly installments for Part D enrollees, but they must…
Revolutionizing Mental Health: 5 Innovative Workplace Strategies
Understanding Mental Health in the Legal Profession
Have you ever wondered if understanding the brain can protect you from mental health issues? Years ago, a Ph.D. holder in neuroscience who worked as a patent lawyer specializing in biotechnology and pharmaceuticals learned it couldn't. Despite understanding neurotransmitters, stress physiology,…
Multigenerational Living: A Cost-Saving Strategy Amid Rising Expenses
Explore an intimate conversation with Teri Carlyle, who discusses her experience with multigenerational living and…
NC households can receive $14,000 to replace furnaces with heat pumps
Residents in North Carolina may soon switch from old, fossil-fuel heating equipment to electric heat pumps,…
VA Tennessee Valley Healthcare Receives Funding for Maintenance Projects in 2026
VA Tennessee Valley Healthcare System receives funding for maintenance projects, contributing to the VA's record $4.8 billion spending in FY 2026.
Quick Round-Up of Important European and Global News by Euronews
Stay updated with the crucial stories from Europe and beyond with Euronews news bulletin, offering a European…
Liberty Justice Center Challenges Trump’s Newest Tariffs in Court
Trump's latest tariffs are challenged in court by Liberty Justice Center, claiming they are a pretext to maintain…
Study: Retratrutide Leads 20% Weight Loss in Diabetes, Heart Patients
Impressive Outcomes from Retatrutide in Clinical Trials
In recent phase 3 clinical trials, the highly anticipated drug retatrutide has shown promising results in terms of weight loss and blood sugar management. The drug manufacturer, Eli Lilly, has revealed that the experimental drug has shown up to almost a 23% decrease in starting body weight,…